©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Pasteurella multocida Toxin, a Potent Intracellularly Acting Mitogen, Induces p125 and Paxillin Tyrosine Phosphorylation, Actin Stress Fiber Formation, and Focal Contact Assembly in Swiss 3T3 Cells (*)

(Received for publication, September 12, 1995; and in revised form, October 20, 1995)

Hadriano M. Lacerda (1)(§) Alistair J. Lax (2) Enrique Rozengurt (1)(¶)

From the  (1)Imperial Cancer Research Fund, London WC2A 3PX, United Kingdom and (2)Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Treatment of Swiss 3T3 cells with recombinant Pasteurella multocida toxin (rPMT), a potent intracellularly acting mitogen, stimulated tyrosine phosphorylation of multiple substrates including bands of M(r) 110,000-130,000 and M(r) 70,000-80,000. Tyrosine phosphorylation induced by rPMT occurred after a pronounced lag period (1 h) and was blocked by either lysosomotrophic agents or incubation at 22 °C. Focal adhesion kinase (p125) and paxillin are prominent substrates for rPMT-stimulated tyrosine phosphorylation. Tyrosine phosphorylation by rPMT could be dissociated from both protein kinase C activation and the mobilization of calcium from intracellular stores. rPMT stimulated striking actin stress fiber formation and focal adhesion assembly in Swiss 3T3 cells. Cytochalasin D, which disrupts the actin cytoskeleton, completely inhibited rPMT-induced tyrosine phosphorylation. In addition, tyrosine phosphorylation of p125 and paxillin in response to rPMT was completely abolished when cells were subsequently treated with platelet-derived growth factor at a concentration (30 ng/ml) that disrupted the actin cytoskeleton. Our results demonstrate for the first time that rPMT, a bacterial toxin, induces tyrosine phosphorylation of p125 and paxillin and promotes actin stress fiber formation and focal adhesion assembly in Swiss 3T3 cells.


INTRODUCTION

The mechanism of action of bacterial toxins has provided insights into the control of cellular regulatory processes, including signal transduction and cell proliferation(1, 2, 3) . Recombinant Pasteurella multocida toxin (rPMT) (^1)is an extremely potent mitogen for murine Swiss 3T3 cells, other fibroblast cell lines, and early-passage cultures and promotes anchorage-independent growth of Rat-1 cells(4, 5) . The toxin is a 146-kDa protein that has been purified, cloned, and sequenced(6, 7, 8, 9, 10, 11, 12, 13) . The deduced amino acid sequence of PMT shows partial homology with CNF1 and CNF2, produced by some strains of pathogenic Escherichia coli(14, 15) . It has been proposed that PMT enters the cells and acts intracellularly to initiate and sustain DNA synthesis.

Prior to the stimulation of DNA synthesis, rPMT stimulates the formation of inositol phosphates and mobilizes Ca from an intracellular pool(16) . Analysis of the inositol phosphate species generated in response to rPMT strongly suggests that the toxin stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by activating cellular phospholipase C(16) , a major transducer of transmembrane signaling (17) . rPMT also increases the cellular content of diacylglycerol, causes translocation of PKC to cellular membranes, and stimulates the phosphorylation of 80K/MARCKS(4, 18) , a prominent substrate of PKC in cultured fibroblasts(19, 20, 21, 22) . The stimulation of these early events by rPMT, like its mitogenic action(5) , requires cellular entry and activation of the toxin.

Changes in protein tyrosine phosphorylation are known to play a key role in the action of growth factors and oncogenes but have not been demonstrated in response to rPMT. Recently, tyrosine phosphorylation of the cytosolic protein kinase p125(23, 24) and of the cytoskeleton-associated protein paxillin (25, 26) have been identified as early events in the action of diverse signaling molecules that mediate cell growth and differentiation including mitogenic neuropeptides(27, 28, 29) , the bioactive lipids LPA and sphingosine (30, 31, 32) , extracellular matrix proteins(33, 34, 35, 36, 37) , PDGF at low concentration(38) , and transforming variants of pp60(33, 39) . The increases in p125 and paxillin tyrosine phosphorylation are accompanied by profound alterations in the organization of the actin cytoskeleton and in the assembly of the focal adhesion plaques(31, 38, 40, 41) , the distinct sites in the plasma membrane where both p125 and paxillin are localized(23, 24, 42) . The effects of rPMT on protein tyrosine phosphorylation, actin stress fiber formation and focal adhesion assembly were unknown.

Here we report that rPMT stimulates tyrosine phosphorylation of multiple proteins including p125 and paxillin and induces a striking increase in stress fiber formation and focal adhesion assembly in Swiss 3T3 cells. The mode of action of rPMT differs from that of neuropeptides, growth factors, and extracellular matrix proteins in that the toxin appears to enter the cells to trigger protein tyrosine phosphorylation and cytoskeletal reorganization.


EXPERIMENTAL PROCEDURES

Cell Culture

Stock cultures of Swiss 3T3 fibroblasts were maintained in DMEM supplemented with 10% FBS in a humidified atmosphere containing 10% CO(2) and 90% air at 37 °C. For experimental purposes, cells were plated either in 30-mm Nunc Petri dishes at 10^5 cells/dish, or in 90-mm dishes at 6 times 10^5 cells/dish, in DMEM containing 10% fetal bovine serum and used after 6-8 days when the cells were confluent and quiescent(43) .

Immunoprecipitation

Quiescent cultures of Swiss 3T3 cells (1-2 times 10^6) were washed twice with DMEM, treated with rPMT or other factors in 10 ml of DMEM/Waymouth 1:1 (v/v) for the times indicated, and lysed at 4 °C in 1 ml of a lysis buffer solution containing 10 mM Tris/HCl, pH 7.6, 5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 100 µM Na(3)VO(4), and 1% Triton X-100. Proteins were immunoprecipitated at 4 °C overnight with agarose-linked mAbs directed against phosphotyrosine, paxillin, or p125 as indicated. Immunoprecipitates were washed three times with lysis buffer and extracted for 10 min at 95 °C in 2 times SDS-PAGE sample buffer (200 mM Tris/HCl, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, 10% glycerol, pH 6.8) and analyzed by SDS-PAGE.

Western Blotting

Treatment of quiescent cultures of cells with factors, cell lysis, and immunoprecipitations were performed as described above. After separation by SDS-PAGE, proteins were transferred to Immobilon membranes(44) . Membranes were blocked using 5% nonfat dried milk in PBS, pH 7.2, and incubated for 3-5 h at 22 °C with a mixture of PY20 and 4G10 anti-Tyr(P) mAbs (1 µg/ml of each). Immunoreactive bands were visualized using I-labeled sheep anti-mouse IgG followed by autoradiography. Autoradiograms were scanned using an LKB Ultrascan XL internal integrator. The values expressed represent percentages of the maximum increase in tyrosine phosphorylation above control values.

P Labeling of Cells and Analysis of 80K/MARCKS Phosphorylation

Quiescent and confluent cultures of Swiss 3T3 cells in 30-mm dishes were washed twice in phosphate-free DMEM and incubated at 37 °C with this medium containing 50 µCi/ml carrier-free [P]P(i). After 12 h, various factors were added for the indicated times. The cells were subsequently lysed, and the lysates were immunoprecipitated with specific anti-80K/MARCKS antibody(45) .

Immunostaining of Cells

Quiescent Swiss 3T3 cells were washed twice with DMEM and incubated for the indicated time in DMEM/Waymouth medium 1:1 (v/v) at 37 °C with the indicated concentration of rPMT or other factors. For actin staining, cells were washed once with PBS, fixed in 4% paraformaldehyde in PBS for 10 min at room temperature, and permeabilized with PBS containing 0.2% Triton X-100 for 8 min at room temperature. The cells were then incubated with TRITC-conjugated phalloidin (0.25 µg/ml) in PBS for 10 min at room temperature and visualized utilizing a Zeiss Axiophot immunofluorescence microscope. In experiments in which quiescent Swiss 3T3 cells were labeled with both TRITC-conjugated phalloidin and anti-vinculin antibody, the cells were fixed and permeabilized as described above and then stained with a mixture of TRITC-conjugated phalloidin (0.25 µg/ml) and anti-vinculin antibody (dilution 1:100) for 30 min at room temperature. Cells were subsequently washed three times in PBS and then incubated with FITC-labeled anti-mouse IgG as a second antibody at a dilution of 1:100 for another 30 min at room temperature.

Microinjection

For C3 exoenzyme microinjection experiments Swiss 3T3 cells were plated in 30-mm dishes at 10^5 cells/dish in DMEM containing 10% fetal bovine serum and used after 6-8 days when the cells were confluent and quiescent. To facilitate localization of microinjected cells, a circle was scored on the bottom of the dishes, and in each experiment approximately 60 adjacent cells in the circle were microinjected. The efficiency of injection was determined by co-injecting rabbit immunoglobulin at 0.5 mg/ml followed by staining of the cells with FITC-conjugated anti-rabbit IgG antibody. Cells were stained with 4G10 mAb directed against phosphotyrosine residues and visualized by confocal microscopy using Cy5-linked anti-mouse IgG.

Confocal Microscopy

Confocal imaging was performed using a Bio-Rad MRC 600 laser scanning head fitted to a Nikon Optiphot microscope. A 40times numerical aperture/1.4 planapochromat oil immersion lens (Nikon) was used for all imaging. FITC- and TRITC-conjugated phalloidin fluorochromes were excited at 488 and 568 nm, respectively, using a krypton/argon mixed gas laser (Bio-Rad). Two filter blocks were used, K1 and K2. K1 is a double dichromic filter enabling excitation at the wavelengths of 488 and 568 nm, whereas the K2 filter is a 560-nm dichromic combined with 522-nm green emission and 585-nm red emission filters. Images were collected using the Kalman filter. Care was taken to ensure that the TRITC-conjugated phalloidin channel was sufficiently bright relative to the fluorescein signal to minimize the contribution of bleed-through from the green channel into the red channel (approximately 10%). Correction of images for bleed-through and other processing was carried out using COMOS and SOM programs (Bio-Rad) run on a Compaq Deskpro 66M 486 computer (66 MHz). Data are presented as projections of sequential optical sections. For Z-series, optical sections were recorded at 0.5 µm. Final images were photographed directly from the VDU screen (see Fig. 4, Fig. 6, and Fig. 8).


Figure 4: Effect of rPMT on the actin cytoskeleton and focal contacts. Quiescent cultures of Swiss 3T3 cells were washed with DMEM and incubated in DMEM:Waymouth medium 1:1(v/v) containing 20 ng/ml rPMT for the times indicated, and then washed with PBS, fixed in 3.7% paraformaldehyde, and permeabilized with 0.2% Triton X-100. A labeling technique with TRITC-conjugated phalloidin and the monoclonal anti-vinculin antibody was used to compare changes in the formation of stress fibers with those of vinculin at the focal adhesions (shown on the left and right, respectively).




Figure 6: Effect of rPMT and PDGF on the actin cytoskeleton. Quiescent cultures of Swiss 3T3 were washed with DMEM and incubated in DMEM:Waymouth medium 1:1(v/v) with (B and D) or without (A and C) 20 ng/ml rPMT for 4 h and further incubated for 10 min as follows: A, no addition; B, 20 ng/ml rPMT; C, 30 ng/ml PDGF; D, 20 ng/ml rPMT + 30 ng/ml PDGF, respectively. Cells were washed with PBS, fixed with 3.7% paraformaldehyde, and permeabilized with 0.2% Triton X-100. Actin was stained by incubation with TRITC-conjugated phalloidin (0.25 µg/ml) in PBS for 10 min at room temperature.




Figure 8: Effect of C3 exoenzyme microinjection on anti-phosphotyrosine staining. Quiescent cultures of Swiss 3T3 cells in 30 mm dishes were washed twice and incubated in DMEM:Waymouth medium 1:1 (v/v). Cells were microinjected (arrows) with 0.5 mg/ml rabbit IgG (CONTROL) or 0.5 mg/ml rabbit IgG + 100 µg/ml C3 (C3 EXOENZYME). Cells were then treated with 20 ng/ml rPMT. After 4 h of incubation, the cells were stained with 4G10 mAb directed against phosphotyrosine residues and visualized by confocal microscopy using Cy5-linked anti-mouse IgG. Microinjected cells were identified by staining with FITC-conjugated anti-rabbit IgG antibody.



Materials

Phorbol 12,13-dibutyrate, bombesin, cytochalasin D, TRITC-conjugated phalloidin, monoclonal anti-vinculin antibody, and FITC-linked anti-mouse IgG were obtained from Sigma. The specific PKC-inhibitor GF109203X and thapsigargin were obtained from Calbiochem-Novabiochem Ltd. Nottingham, UK. Agarose-linked anti-Tyr(P) mAb was purchased from Oncogene Science Inc., Manhasset, NY. PY20 anti-Tyr(P) mAb and the mAb directed against paxillin (mAb 165) were from ICN, High Wycombe, UK. 4G10 anti-Tyr(P) mAb was from Upstate Biotechnology, Inc., Lake Placid, NY. mAb 2A7 directed against p125 was from TCS Biologicals Ltd., Buckingham, UK. p125 immunoblotting was performed with mAb from Transduction Laboratories, Lexington, KY. The anti-Tyr(P) mAb PY72 was obtained from the hybridoma development unit, Imperial Cancer Research Fund. I-labeled sheep anti-mouse IgG (15 mCi/mg), carrier-free [P]P(i), and recombinant BB homodimer PDGF were from Amersham Corp., UK. rPMT was prepared as described previously(13) . All other reagents were of the highest grade commercially available. The C3 Clostridium botulinum exoenzyme was a gift from Dr. N. Morii and Professor S. Narumiya, Department of Pharmacology, Kyoto University Faculty of Medicine, Sakyo-ku 606, Japan.


RESULTS

rPMT Stimulates Tyrosine Phosphorylation in Swiss 3T3 Cells

To examine the effect of rPMT on tyrosine phosphorylation, quiescent cultures of Swiss 3T3 cells were treated with 20 ng/ml rPMT for 6 h, conditions known to result in the stimulation of DNA synthesis (5) . The cells were lysed, the lysates were incubated with agarose linked anti-Tyr(P) mAb, and the resulting immunoprecipitates were analyzed by Western blotting with a mixture of PY20 and 4G10 anti-Tyr(P) mAbs. As shown in Fig. 1A, rPMT markedly stimulated the tyrosine phosphorylation of a group of bands migrating with an apparent M(r) of 110,000-130,000 and 70,000-80,000. The ability of rPMT to induce tyrosine phosphorylation of these proteins was completely abolished by PMT antiserum in a selective manner (Table 1).


Figure 1: rPMT induces tyrosine phosphorylation of multiple bands including p125 and paxillin in Swiss 3T3 cells. A, quiescent cultures of Swiss 3T3 cells were treated in DMEM/Waymouth medium 1:1 (v/v) with (+) or without(-) 20 ng/ml rPMT for 6 h. Cells were lysed and the lysates were immunoprecipitated with agarose-linked anti-Tyr(P) mAb, anti-p125 mAb, 2A7, or anti-paxillin mAb, 165. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by immunoblotting with a mixture of anti-Tyr(P) mAbs. B, quiescent cultures of Swiss 3T3 cells were treated in DMEM/Waymouth medium 1:1 (v/v) with 20 ng/ml rPMT for various times (0-24 h) as indicated. Cells were lysed, and the lysates were immunoprecipitated using anti-Tyr(P) mAb, mAb 2A7, and mAb 165 and analyzed by immunoblotting with a mixture of anti-Tyr(P) mAbs, as described above. The positions of p125 and paxillin are indicated by arrows. The results shown in this and subsequent figures are representatives autoradiographs of at least three independent experiments.





The pattern of tyrosine-phosphorylated proteins induced by rPMT is strikingly similar to that stimulated by bombesin and LPA in Swiss 3T3 cells(27, 31) . Recently, the cytosolic tyrosine kinase p125(23, 24) and the adaptor protein paxillin (25, 26, 46) have been identified as prominent tyrosine-phosphorylated proteins in bombesin and LPA-treated cells(27, 28, 29, 31) . To determine whether these cellular proteins were also substrates for rPMT-induced tyrosine phosphorylation, lysates of Swiss 3T3 cells, incubated with 20 ng/ml rPMT for 6 h, were immunoprecipitated with mAbs that recognize either p125 or paxillin, and the immunoprecipitates were analyzed by Western blotting with a mixture of anti-Tyr(P) mAbs. Fig. 1A, shows that rPMT markedly stimulated p125 and paxillin tyrosine phosphorylation. Thus, p125 is a component of the broad M(r) 110,000-130,000 band, whereas paxillin is a component of the diffuse tyrosine-phosphorylated band migrating with an apparent M(r) 70,000-80,000.

rPMT Enters the Cells to Elicit Tyrosine Phosphorylation

Several lines of evidence presented here indicate that rPMT has to enter cells to induce tyrosine phosphorylation of multiple proteins including p125 and paxillin. (i) Neuropeptides and LPA elicit maximum tyrosine phosphorylation of p125 and paxillin within minutes of addition to the cell cultures. In contrast, there is a lag period of 1 h between the addition of 20 ng/ml PMT and a detectable increase in tyrosine phosphorylation of these proteins (Fig. 1B). This lag period did not reflect a requirement for de novo protein synthesis as cycloheximide at 25 µM, a concentration that inhibits protein synthesis in Swiss 3T3 cells(47) , did not prevent the increase in protein tyrosine phosphorylation in response to 20 ng/ml rPMT. In addition, we verified that similar amounts of p125 were recovered after different times of treatment with rPMT (results not shown). Interestingly, the enhanced tyrosine phosphorylation of several proteins including p125 and paxillin induced by rPMT persisted for at least 24 h (Fig. 1B). (ii) The lysosomotrophic agent methylamine, a membrane-permeant weak base known to inhibit lysosomal processing, completely blocked tyrosine phosphorylation of the M(r) 110,000-130,000 and M(r) 70,000-80,000 bands in response to rPMT. The inhibitory effect of methylamine was selective because it did not prevent the increase in tyrosine phosphorylation induced by bombesin in parallel cultures (Fig. 2, A and B). (iii) The entry of many bacterial toxins into the cell cytoplasm is temperature-dependent(48) . As shown in Fig. 2, A and B, treatment with 20 ng/ml rPMT for 6 h at 22 °C failed to stimulate tyrosine phosphorylation in Swiss 3T3 cells. In contrast, bombesin induced tyrosine phosphorylation of M(r) 110,000-130,000 and M(r) 70,000-80,000 bands in parallel cultures of these cells incubated at 22 °C. (iv) Many bacterial toxins that enter the cells cannot be removed by extensive washing(1) . Fig. 2C demonstrates that the increase in tyrosine phosphorylation in rPMT-treated cells persisted after removal of the toxin from the extracellular medium. A transient exposure of cells to the toxin for 3-h stimulated maximum tyrosine phosphorylation. Thus, the toxin appears to enter the cells via an endosomal/lysosomal pathway where it is processed and then released into the cytosol in an active form.


Figure 2: Effect of methylamine, temperature, and exposure time on rPMT-induced tyrosine phosphorylation. A, quiescent cultures of Swiss 3T3 cells were incubated for 6 h in DMEM:Waymouth 1:1(v/v) medium containing 20 ng/ml rPMT or 10 nM bombesin with or without 10 mM CH(3)NH(2) at 37 °C. Other cultures were incubated with either rPMT or bombesin under identical conditions except that the temperature of incubation was 22 °C instead of at 37 °C. Cells were lysed and the lysates immunoprecipitated with anti-Tyr(P) mAb. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by anti-Tyr(P) immunoblotting. B, the values of the mean of three independent experiments which are expressed as the percentage of the maximum stimulation of tyrosine phosphorylation by 20 ng/ml rPMT of the M(r) 110,000-130,000 band quantified by scanning densitometry. C, quiescent cultures of Swiss 3T3 cells were treated with 20 ng/ml rPMT for various times (0-5 h) as indicated. The cells fresh DMEM:Waymouth medium (1:1). The incubation was terminated at were then washed with DMEM and subsequently incubated (5-0 h) with the end of the 5 h period.



Role of PKC and Ca^2 on rPMT-induced Tyrosine Phosphorylation

rPMT induces a striking mobilization of Ca and stimulation of PKC in Swiss 3T3 cells (16, 18, 49) . It is known that PKC activation leads to increased tyrosine phosphorylation of p125 and paxillin (28, 29) . Consequently, we examined whether these signaling pathways could be involved in rPMT-induced tyrosine phosphorylation.

To determine whether rPMT acts through a PKC-dependent pathway, cells were pretreated for 60 min with the selective PKC inhibitor, GF109203X(50) , at 3.5 µM, a concentration that completely abolished phorbol 12,13-dibutyrate-induced tyrosine phosphorylation of p125 in Swiss 3T3 cells(29) . The cells were subsequently challenged with 20 ng/ml rPMT for a further 5 h. rPMT-induced tyrosine phosphorylation of p125 was not significantly reduced (Fig. 3A). In the same experiment, tyrosine phosphorylation induced by 200 nM phorbol 12,13-dibutyrate for 5 h was completely inhibited by GF109203X (data not shown).


Figure 3: Effect of GF109203X and thapsigargin on the stimulation of tyrosine phosphorylation of p125 by rPMT. A, quiescent Swiss 3T3 cells were preincubated for 1 h with GF109203X (+) or an equivalent amount of solvent(-) and then stimulated with 20 ng/ml rPMT for a further 5 h. Cells were lysed and the lysates immunoprecipitated with mAb 2A7 directed against p125 and further analyzed by Western blotting with anti-Tyr(P) mAbs. B, quiescent Swiss 3T3 cells were pretreated with 30 nM thapsigargin (+) or an equivalent amount of solvent(-) for 30 min. Cells were then stimulated with 20 ng/ml rPMT, incubated for a further 6 h and subsequently lysed. The lysates were immunoprecipitated with mAb 2A7 against p125 and Western blotted with anti-Tyr(P) mAbs. Anti-Tyr(P) immunoreactivity of the p125 band was quantified by scanning densitometry. A and B show the values of the mean of three independent experiments and are expressed as the percentage of the maximum stimulation by 20 ng/ml rPMT.



To investigate whether Ca mobilization mediates tyrosine phosphorylation by rPMT, quiescent cells were pretreated with the tumor promoter thapsigargin. Thapsigargin depletes Ca from intracellular stores by specifically inhibiting the endoplasmic reticulum Ca-ATPase (51) . Pretreatment of cells with 30 nM thapsigargin for 30 min which depletes Ca from internal stores in Swiss 3T3 cells (29, 31) had no effect on the subsequent rPMT-induced tyrosine phosphorylation of p125 (Fig. 3B). Thus, rPMT stimulates tyrosine phosphorylation of p125 largely through a PKC- and Ca-independent pathway.

rPMT Stimulates Actin Stress Fiber and Focal Contact Formation

Given the localization of p125 and paxillin to focal contacts, which form at the end of actin stress fibers, we examined the effect of rPMT on actin cytoskeleton organization and focal adhesion assembly. Actin filaments were visualized with TRITC-labeled phalloidin, and vinculin was detected by immunofluorescence with a anti-vinculin mAb. As shown in Fig. 4, quiescent Swiss 3T3 cells have few actin stress fibers. Addition of 20 ng/ml rPMT to quiescent Swiss 3T3 cells induced a striking increase in the formation of actin stress fibers. Formation of new stress fibers was detected after a lag period of approximately 1 h and reached a maximum after 8 h when the cells contained numerous densely packed stress fibers (Fig. 4, left).

Focal adhesions are subcellular structures which are formed at regions of close contact between cells and their underlying substratum. Several proteins are specifically localized in focal adhesions including vinculin, paxillin, talin, and alpha-actinin(52) . Here we demonstrate that addition of rPMT to quiescent Swiss 3T3 cells induced localization of vinculin into focal adhesions, first visible after 1 h and reaching a maximum after 8 h (Fig. 4, right). Addition of 25 µM cycloheximide did not prevent the localization of vinculin into focal contacts induced by rPMT (results not shown). The relative amount of vinculin in focal adhesions, as judged by the intensity of immunofluorescent staining, increased in parallel with the association of stress fibers at these sites of the plasma membrane. Thus, rPMT induced actin stress fiber formation and focal adhesion assembly in Swiss 3T3 cells with kinetics that closely parallels rPMT induced tyrosine phosphorylation of p125 and paxillin.

Cytochalasin D Inhibits rPMT-stimulated Tyrosine Phosphorylation of Multiple Bands Including p125

The striking effects of PMT on stress fiber formation and focal adhesion assembly shown in Fig. 4prompted us to examine whether the integrity of the actin filament network is necessary for rPMT stimulated tyrosine phosphorylation. Quiescent Swiss 3T3 cells were pretreated for 1 h with increasing concentrations of cytochalasin D and then stimulated with 20 ng/ml rPMT for 6 h. Cytochalasin D blocked rPMT-induced tyrosine phosphorylation of all phosphorylated bands including tyrosine phosphorylation of p125 in a similar, concentration-dependent manner (Fig. 5A). A complete inhibition of p125 tyrosine phosphorylation was achieved at the concentration of 1.2 µM cytochalasin D.


Figure 5: Cytochalasin D inhibits rPMT-stimulated tyrosine phosphorylation of multiple bands including p125. A, quiescent cultures of Swiss 3T3 cells were treated for 1 h in the presence of various concentrations of cytochalasin D as indicated and then 20 ng/ml rPMT was added to the cell cultures and incubated for a further 6 h. The cells were then lysed and the lysates immunoprecipitated using anti-Tyr(P) mAb or 2A7 mAb directed against p125. The immunoprecipitates were fractionated by SDS-PAGE and further analyzed by immunoblotting using a mixture of anti-Tyr(P) mAbs. The position of p125 is indicated by an arrow. B, quiescent cells, labeled with 50 µCi/ml of [P]P(i) for 12 h, were treated with (+) or without(-) 1.2 µM cytochalasin D for 1 h. Then, some of the cultures received 20 ng/ml rPMT and all cultures were incubated for a further 6 h. Cells were subsequently lysed and the lysates were immunoprecipitated with anti-80K/MARCKS antibody and further analyzed by SDS-PAGE.



The inhibitory effect of cytochalasin D may, in theory, have resulted from interference with the entry and activation of PMT. To examine this possibility we tested the ability of rPMT to activate PKC and phosphorylate 80K/MARCKS in cells treated in the absence or presence of cytochalasin D. Quiescent Swiss 3T3 cells labeled with [P]P(i) for 12 h, were pretreated with 1.2 µM cytochalasin D for 1 h and then challenged with 20 ng/ml rPMT for further 6 h. Fig. 5B shows that treatment with cytochalasin D at a concentration that completely inhibited rPMT-induced tyrosine phosphorylation did not prevent rPMT mediated stimulation of 80K/MARCKS phosphorylation.

Effect of High Concentrations of PDGF on rPMT-induced Actin Stress Fiber Formation and p125 Tyrosine Phosphorylation

Recent data from our laboratory have shown that PDGF at high concentrations (30 ng/ml) abolishes bombesin- and LPA-induced actin stress fiber and focal contacts(31, 38) . This prompted us to investigate the effect of PDGF on rPMT induced stress fiber formation. Quiescent Swiss 3T3 cells were treated with 20 ng/ml rPMT for 4 h, and then 30 ng/ml PDGF was added for 10 min. Cells were then fixed and stained with TRITC-conjugated phalloidin. As shown in Fig. 6B, rPMT caused a marked increase in stress fiber formation, whereas 30 ng/ml PDGF caused disruption of the actin stress fibers and retraction of cell bodies (Fig. 6C). Interestingly, addition of 30 ng/ml PDGF to rPMT-treated cells reduced the number of actin stress fibers (Fig. 6D) and focal contacts (results not shown) induced by rPMT. The remaining stress fibers in rPMT- and PDGF-treated cells lost their unidirectional arrangement as tightly packed bundles. In contrast, PDGF at 5 ng/ml did not disrupt the actin reorganization induced by rPMT (results not shown).

As shown previously in Fig. 5, rPMT-induced tyrosine phosphorylation requires the integrity of the actin cytoskeleton. Given that 30 ng/ml PDGF also destabilized the actin stress fibers we decided to investigate the effects of PDGF on tyrosine phosphorylation induced by rPMT. Quiescent Swiss 3T3 cells were treated with 20 ng/ml rPMT for 4 h and then 5 ng/ml or 30 ng/ml PDGF were added to the cells for further 10 min. As shown in Fig. 7, rPMT induced tyrosine phosphorylation of either p125 or paxillin was markedly inhibited by addition of 30 ng/ml PDGF but not by 5 ng/ml PDGF.


Figure 7: PDGF blocks tyrosine phosphorylation of p125 and paxillin induced by rPMT. Quiescent cultures of Swiss 3T3 were incubated with or without rPMT for 4 h. Subsequently, 5 or 30 ng/ml PDGF was added (+) to rPMT pretreated cells, as well as nontreated cells, for an additional 10 min. Cells were lysed and the lysates immunoprecipitated with 2A7 mAb against p125 (A) or 165 mAb against paxillin (B). The immunoprecipitates were analyzed by SDS-PAGE followed by immunoblotting using anti-Tyr(P) mAbs. Values shown are expressed as a percentage of the maximum tyrosine phosphorylation of p125 or paxillin stimulated by 20 ng/ml rPMT.



Microinjection of C. botulinum C3 Exoenzyme Inhibits rPMT-induced Tyrosine Phosphorylation at Focal Contacts

The rho gene product p21 has been implicated in the neuropeptide-stimulated formation of focal adhesions, actin stress fibers, and in tyrosine phosphorylation of p125 and paxillin(40, 53, 54, 55) . To investigate the role of p21 in the rPMT-stimulated tyrosine phosphorylation of focal adhesion-associated proteins we utilized the C. botulinum C3 exoenzyme which ADP-ribosylates Asn of p21 and thereby prevents its function(56) . Recombinant C3 exoenzyme was microinjected at a concentration of 100 µg/ml into confluent and quiescent Swiss 3T3 cells, and the cultures were further treated with 20 ng/ml rPMT for 4 h. Cells were then fixed, permeabilized and stained for tyrosine phosphorylated proteins which are predominantly localized at the focal contacts in rPMT treated cells (Fig. 8). The tyrosine phosphorylation of focal adhesion proteins in response to rPMT was profoundly inhibited in cells microinjected with C3 exoenzyme (indicated by the arrows in Fig. 8, right). In parallel experiments, Swiss 3T3 cells were microinjected only with immunoglobulin and then stimulated with 20 ng/ml rPMT. These cells display the typical pattern of tyrosine phosphorylated proteins demonstrating that microinjection itself did not interfere with rPMT-induced tyrosine phosphorylation of focal adhesion proteins (Fig. 8, left).


DISCUSSION

The results presented here show for the first time that rPMT, an intracellularly acting bacterial toxin, induces tyrosine phosphorylation of multiple substrates in Swiss 3T3 cells. In this study, we identified two substrates, p125 and paxillin, which were tyrosine-phosphorylated in response to rPMT. p125 is a cytosolic tyrosine protein kinase localized in focal adhesions that lacks SH2 and SH3 domains but associates with other proteins including v-Src and paxillin(23, 24, 46) . Paxillin, a M(r) 70,000 protein, is a major phosphotyrosyl protein in chicken embryo and like p125, is localized to focal adhesions(41, 42) . Recent molecular cloning revealed that paxillin is a multidomain protein that may function as an adaptor capable of associating with p125, Crk, and Src(25, 26, 46) . A coordinate increase in tyrosine phosphorylation of p125 and paxillin is induced by a variety of molecules that regulate cell growth and differentiation(27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38) . Our results suggest that p125 and paxillin tyrosine phosphorylation could also play a role in the signaling pathways stimulated by rPMT.

rPMT increases the accumulation of the second messengers diacylglycerol and inositol 1,4,5-trisphosphate, which activate PKC and mobilize Ca from intracellular stores, respectively (49) , and direct PKC activation is known to stimulate tyrosine phosphorylation of p125 and paxillin(27, 29) . However, neither a selective inhibitor of PKC nor depletion of intracellular Ca stores blocked the rPMT-stimulated tyrosine phosphorylation of p125. Thus, rPMT induces tyrosine phosphorylation of p125 by a pathway largely independent of PKC activation and Ca mobilization.

The effects of many bacterial toxins require them to bind and enter cells via endocytotic pathways(1, 57, 58) . Activation of some bacterial toxins is believed to occur during their transit through the endosomal/lysosomal compartments. In these acidic compartments, the toxin may be activated by proteolysis or by conformational changes. Interestingly, rPMT becomes susceptible to proteolysis at lysosomal pH values(59) . Membrane-permeant weak bases that increase the pH of the acidic intracellular compartments block the process of activation. The characteristic lag period in the action of many toxins is a manifestation of the complex events of entry and activation. Several lines of evidence indicate that the stimulation of protein tyrosine phosphorylation by rPMT also requires cell entry and activation of the toxin. For example, rPMT induced tyrosine phosphorylation of multiple substrates including p125 and paxillin after a pronounced (1 h), cycloheximide-insensitive, lag period and its effect was selectively blocked by the lysosomotrophic agent methylamine or by reducing the temperature of incubation to 22 °C, which prevents vesicular trafficking(48) . Other responses induced by rPMT, including polyphosphoinositide hydrolysis, Ca mobilization, PKC activation, and commitment to DNA synthesis exhibit similar characteristics(5, 16, 18) . Recently, colloidal gold-labeled rPMT has been shown to be rapidly internalized into endocytic vesicles in toxin-sensitive cell lines(60) . Together, these findings suggest that rPMT enters the cells via endosomal/lysosomal compartments and then initiates events leading to the activation of signal transduction pathways, including p125 and paxillin tyrosine phosphorylation.

Tyrosine phosphorylation of p125 and paxillin stimulated by bombesin, LPA, sphingosine, and PDGF is closely related to changes in the organization of the actin microfilament network induced by these ligands in Swiss 3T3 cells(29, 31, 38) . The cytoskeletal changes induced by LPA and bombesin require functional p21 protein(40) . In addition, bombesin and LPA stimulate tyrosine phosphorylation by a pathway critically dependent on the integrity of the actin cytoskeleton(28, 29, 31) . These findings raised the possibility that tyrosine phosphorylation of p125 and paxillin, actin stress fiber formation, focal adhesion assembly and p21 function may lie in a novel signal transduction pathway. Having established that rPMT induces p125 and paxillin tyrosine phosphorylation, it was, therefore, of interest to determine whether this toxin can also induce changes in the organization of the actin cytoskeleton. In addition, the polymerization of the actin cytoskeleton has been postulated to play an important role in the endocytosis of many bacteria by animal cells(61) .

Here we report that rPMT elicits dramatic cytoskeletal responses in quiescent Swiss 3T3 cells. Specifically, rPMT induces striking formation of actin stress fibers and focal adhesion plaques in these cells. This is the first time that rPMT has been shown to induce accumulation of actin stress fibers and to promote focal adhesion assembly in any cell type. PMT shows amino acid sequence homology with the NH(2)-terminal region of CNF1 and CNF2 produced by pathogenic E. coli strains(14, 15) . Interestingly, the E. coli toxins have been shown to induce reorganization of actin cytoskeleton which has been postulated to block cytokinesis leading to multinucleated cells. In contrast, rPMT induces actin reorganization that does not interfere with cell division since rPMT promotes striking proliferation in fibroblast cell lines(4, 5) . It would be interesting, therefore to compare the cytoskeletal responses induced by these toxins in the same cell type.

The kinetics of the cytoskeletal responses induced by rPMT closely parallel the time course of rPMT stimulated tyrosine phosphorylation. Pretreatment of quiescent Swiss 3T3 with cytochalasin D completely disrupted the actin cytoskeleton and blocked the tyrosine phosphorylation of p125 stimulated by rPMT. Thus, the integrity of the actin cytoskeleton is essential for rPMT induced tyrosine phosphorylation.

Recent results from our laboratory revealed that PDGF at high concentrations caused disruption of the actin cytoskeleton(31, 38) . As tyrosine phosphorylation and actin stress fiber formation induced by rPMT appear to be closely linked in Swiss 3T3 cells, we examined a possible cross-talk between PDGF and rPMT on actin stress fiber organization and p125 tyrosine phosphorylation. PDGF at a high concentration (30 ng/ml) profoundly inhibited rPMT induced tyrosine phosphorylation of p125 establishing a novel cross-talk between PDGF and rPMT on tyrosine phosphorylation. This can be explained by the ability of PDGF to interfere with rPMT induced actin stress fiber organization and focal adhesion assembly in rPMT-treated cells.

In view of these results it was plausible, that p21 could also be involved in rPMT induced cytoskeletal changes and tyrosine phosphorylation. Microinjection of C3 C. botulinum exoenzyme, which ADP-ribosylates and inactivates p21 function, prevented tyrosine phosphorylation of focal adhesion proteins in response to rPMT. Thus, p21 is upstream of tyrosine phosphorylation in response to rPMT.

Most normal cells require contact with an adhesive substratum to proliferate and oncogenic transformation removes this requirement for adherence(62) . Integrin-mediated signals, including tyrosine phosphorylation of focal adhesion proteins (34, 35, 36, 37) have been implicated in promoting anchorage-dependent growth(41, 63, 64) . It is conceivable that growth factors and oncogenes that induce anchorage-independent growth mimic integrin-mediated signals. Interestingly, we have previously reported that rPMT is a potent inducer of anchorage-independent colony formation in certain target cells(4) . A salient feature of the results presented here is that the striking increase in p125 and paxillin tyrosine phosphorylation, actin stress fiber formation and focal adhesion assembly induced by rPMT remain undiminished even after 24 h of incubation. It is tempting to speculate that rPMT circumvents the requirement for integrin-mediated signals generated in adherent cells as a result of its striking and persistent effects on the organization of the cytoskeleton and the tyrosine phosphorylation of focal adhesion proteins, a proposition that deserves further experimental work.

In conclusion, our results demonstrate, for the first time, that rPMT stimulates tyrosine phosphorylation of multiple bands including p125 and paxillin. Furthermore, rPMT induces striking increase in the formation of actin stress fiber and focal adhesion assembly in Swiss 3T3 cells. The integrity of the polymerized actin network and functional p21 are essential for rPMT-induced tyrosine phosphorylation. To our knowledge, this is the first time, that an intracellularly acting bacterial toxin has been shown to induce protein tyrosine phosphorylation in animal cells.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Recipient of a Research Fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brasilia.

To whom all correspondence should be addressed: Imperial Cancer Research Fund, P.O. Box 123, 44 Lincoln's Inn Fields, London WC2A 3PX, UK. Tel.: 44-0171-269-3455; Fax: 44-0171-269-3417.

(^1)
The abbreviations used are: PMT, Pasteurella multocida toxin; rPMT, recombinant PMT; CNF, cytotoxic necrotizing factor; Tyr(P), phosphotyrosine; DMEM, Dulbecco's modified Eagle's medium; mAb, monoclonal antibody; PBS, phosphate-buffered saline; PDGF, platelet-derived growth factor; p125, p125 focal adhesion kinase; PKC, protein kinase C; TRITC, tetreamethylrhodamine B isothiocyanate; PAGE, polyacrylamide gel electrophoresis; FITC, fluorescein isothiocyanate; LPA, lysophosphatidic acid.


REFERENCES

  1. Middlebrook, J. C., and Dorland, R. B. (1984) Microbiol. Rev. 48, 199-221
  2. Moss, J., and Vaughn, M. (1988) Adv. Enzymol. 61, 303-379 [Medline] [Order article via Infotrieve]
  3. Bourne, H. R., Sanders, D. A., and McCormick, F. (1990) Nature 348, 125-131 [CrossRef][Medline] [Order article via Infotrieve]
  4. Higgins, T. E., Murphy, A. C., Staddon, J. M., Lax, A. J., and Rozengurt, E. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4240-4244 [Abstract]
  5. Rozengurt, E., Higgins, T., Chanter, N., Lax, A. J., and Staddon, J. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 123-127 [Abstract]
  6. Buys, W. E. C. M., Smith, H. E., Kamps, A. M. I. E., Kamp, E. M., and Smits, M. A. (1990) Nucleic Acids Res. 18, 2815-2816 [Medline] [Order article via Infotrieve]
  7. Lax, A. J., Chanter, N., Pullinger, G. D., Higgins, T., Staddon, J. M., and Rozengurt, E. (1990) FEBS Lett. 277, 59-64 [CrossRef][Medline] [Order article via Infotrieve]
  8. Chanter, N., Rutter, J. M., and Mackenzie, A. (1986) J. Gen. Microbiol. 132, 1089-1097 [Medline] [Order article via Infotrieve]
  9. Nakai, T., Sawata, A., Tsuji, M., Samejima, Y., and Kume, K. (1984) Infect. Immun. 46, 429-434 [Medline] [Order article via Infotrieve]
  10. Foged, N. T., Pederson, K. B., and Elling, F. (1987) FEMS Microbiol. Lett. 43, 45-51
  11. Foged, N. T. (1988) Infect. Immun. 56, 1901-1906 [Medline] [Order article via Infotrieve]
  12. Petersen, S. K., and Foged, N. T. (1989) Infect. Immun. 57, 3907-3913 [Medline] [Order article via Infotrieve]
  13. Lax, A. J., and Chanter, N. (1990) J. Gen. Microbiol. 136, 81-87 [Medline] [Order article via Infotrieve]
  14. Caprioli, A., Falbo, V., Roda, L. G., Ruggeri, F. M., and Zona, C. (1983) Infect. Immun. 39, 1300-1306 [Medline] [Order article via Infotrieve]
  15. Oswald, E., Sugai, M., Labigne, A., Wu, W., Fiorentini, C., Boquet, P., and O'Brien, A. D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3814-3818 [Abstract]
  16. Staddon, J. M., Barker, C. J., Murphy, A. C., Chanter, N., Lax, A. J., Michell, R. H., and Rozengurt, E. (1991) J. Biol. Chem. 266, 4840-4847 [Abstract/Free Full Text]
  17. Berridge, M. J. (1993) Nature 361, 315-325 [CrossRef][Medline] [Order article via Infotrieve]
  18. Staddon, J. M., Chanter, N., Lax, A. J., Higgins, T. E., and Rozengurt, E. (1990) J. Biol. Chem. 265, 11841-11848 [Abstract/Free Full Text]
  19. Blackshear, P. J., Wen, L., Glynn, B. P., and Witters, L. A. (1986) J. Biol. Chem. 261, 1459-1469 [Abstract/Free Full Text]
  20. Rozengurt, E., Rodriguez-Pena, A., and Smith, K. A. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 7224-7248 [Abstract]
  21. Rodriguez-Pena, A., and Rozengurt, E. (1986) EMBO J. 5, 77-83 [Abstract]
  22. Brooks, S. F., Herget, T., Erusalimsky, J. D., and Rozengurt, E. (1991) EMBO J. 10, 2497-2505 [Abstract]
  23. Hanks, S. K., Calalb, M. B., Harper, M. C., and Patel, S. K. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8487-8491 [Abstract]
  24. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., and Parsons, J. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5192-5196 [Abstract]
  25. Salgia, R., Li, J.-L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T., Tantravahi, R., Chen, L. B., and Griffin, J. D. (1995) J. Biol. Chem. 270, 5039-5047 [Abstract/Free Full Text]
  26. Turner, C. E., and Miller, J. T. (1994) J. Cell Sci. 107, 1583-1591 [Abstract/Free Full Text]
  27. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. (1992) J. Biol. Chem. 267, 19031-19034 [Abstract/Free Full Text]
  28. Zachary, I., Sinnett-Smith, J., Turner, C. E., and Rozengurt, E. (1993) J. Biol. Chem. 268, 22060-22065 [Abstract/Free Full Text]
  29. Sinnett-Smith, J., Zachary, I., Valverde, A. M., and Rozengurt, E. (1993) J. Biol. Chem. 268, 14261-14268 [Abstract/Free Full Text]
  30. Kumagai, N., Morii, N., Fujisawa, K., Yoshimasa, T., Nakao, K., and Narumiya, S. (1993) FEBS Lett. 329, 273-276 [CrossRef][Medline] [Order article via Infotrieve]
  31. Seufferlein, T., and Rozengurt, E. (1994) J. Biol. Chem. 269, 9345-9351 [Abstract/Free Full Text]
  32. Seufferlein, T., and Rozengurt, E. (1994) J. Biol. Chem. 269, 27610-27617 [Abstract/Free Full Text]
  33. Guan, J. L., and Shalloway, D. (1992) Nature 358, 690-692 [CrossRef][Medline] [Order article via Infotrieve]
  34. Kornberg, L., Earp, H. S., Parsons, J. T., Schaller, M., and Juliano, R. L. (1992) J. Biol. Chem. 267, 23439-23442 [Abstract/Free Full Text]
  35. Burridge, K., Turner, C. E., and Romer, L. H. (1992) J. Cell Biol. 119, 893-903 [Abstract]
  36. Lipfert, L., Haimovich, B., Schaller, M. D., Cobb, B. S., Parsons, J. T., and Brugge, J. S. (1992) J. Cell Biol. 119, 905-912 [Abstract]
  37. Vuori, K., and Ruoslahti, E. (1993) J. Biol. Chem. 268, 21459-21462 [Abstract/Free Full Text]
  38. Rankin, S., and Rozengurt, E. (1994) J. Biol. Chem. 269, 704-710 [Abstract/Free Full Text]
  39. Kanner, S. B., Reynolds, A. B., Vines, R. R., and Parsons, J. T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3328-3332 [Abstract]
  40. Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399 [Medline] [Order article via Infotrieve]
  41. Hynes, R. O. (1992) Cell 69, 11-25 [Medline] [Order article via Infotrieve]
  42. Turner, C. E. (1991) J. Cell Biol. 115, 201-207 [Abstract]
  43. Rozengurt, E., and Sinnett-Smith, J. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2936-2940 [Abstract]
  44. Kamps, M. P., and Sefton, B. M. (1989) Anal. Biochem. 176, 22-27 [Medline] [Order article via Infotrieve]
  45. Erusalimsky, J. D., Brooks, S. F., Herget, T., Morris, C., and Rozengurt, E. (1991) J. Biol. Chem. 266, 7073-7080 [Abstract/Free Full Text]
  46. Schaller, M. D., and Parsons, J. T. (1995) Mol. Cell. Biol. 15, 2635-2645 [Abstract]
  47. Lopez-Rivas, A., Adelberg, E. A., and Rozengurt, E. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6275-6279 [Abstract]
  48. Smythe, E., Pypaert, M., Lucocq, J., and Warren, G. (1989) J. Cell Biol. 106, 843-853
  49. Murphy, A. C., and Rozengurt, E. (1992) J. Biol. Chem. 267, 25296-25303 [Abstract/Free Full Text]
  50. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., and Kirilovsky, J. (1991) J. Biol. Chem. 266, 15771-15781 [Abstract/Free Full Text]
  51. Thastrup, O., Cullen, P. J., Drobak, B. K., Hanley, M. R., and Dawson, A. P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2466-2470 [Abstract]
  52. Burridge, K., Fath, K., Kelly, T., Nuckolls, G., and Turner, C. (1988) Annu. Rev. Cell Biol. 7, 337-374 [CrossRef]
  53. Kumagai, N., Morii, N., Fujisawa, K., Nemoto, Y., and Narumiya, S. (1993) J. Biol. Chem. 258, 24535-24538
  54. Rankin, S., Morii, N., Narumiya, S., and Rozengurt, E. (1994) FEBS Lett. 354, 315-319 [CrossRef][Medline] [Order article via Infotrieve]
  55. Seckl, M. J., Morii, N., Narumiya, S., and Rozengurt, E. (1995) J. Biol. Chem. 270, 6984-6990 [Abstract/Free Full Text]
  56. Aktories, K., Weller, U., and Chatwal, G. S. (1987) FEBS Lett. 212, 109-113 [CrossRef][Medline] [Order article via Infotrieve]
  57. Olsnes, S., and Sandvig, K. (1988) Immunotoxins , pp. 39-73, Kluwer Academic Publishers, Norwell, MA
  58. Neville, D. M. J., and Hudson, T. H. (1986) Annu. Rev. Biochem. 55, 195-224 [CrossRef][Medline] [Order article via Infotrieve]
  59. Smyth, M. G., Pickersgill, R. W., and Lax, A. J. (1995) FEBS Lett. 360, 62-66 [CrossRef][Medline] [Order article via Infotrieve]
  60. Pettit, R. K., Ackermann, M. R., and Rimler, R. B. (1995) Lab. Invest. 69, 94 [Medline] [Order article via Infotrieve]
  61. Falkow, S., Isberg, R. R., and Portnoy, D. A. (1992) Annu. Rev. Cell Biol. 8, 333-63 [CrossRef]
  62. Varmus, H. E. (1984) Annu. Rev. Genet. 18, 553-612 [CrossRef][Medline] [Order article via Infotrieve]
  63. Zachary, I., and Rozengurt, E. (1992) Cell 71, 891-894 [Medline] [Order article via Infotrieve]
  64. Rozengurt, E. (1995) Cancer Surv. 24, 81-96 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.